financetom
Business
financetom
/
Business
/
Take-Two Interactive forecasts Q2 bookings below estimates on soft gaming spends
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Take-Two Interactive forecasts Q2 bookings below estimates on soft gaming spends
Aug 8, 2024 1:31 PM

(Reuters) -Videogame publisher Take-Two Interactive Software ( TTWO ) forecast second-quarter bookings below Wall Street expectations on Thursday, a sign of sluggish spending on its popular titles such as "Grand Theft Auto" and "NBA 2K" in an uncertain economy.

The downbeat projection highlights weakness in in-game spending on live-service titles as customers cut back on discretionary purchases amid a cost-of-living crisis and still-high inflation.

The company expects bookings to be between $1.42 billion and $1.47 billion for the second quarter, while analysts on average estimate $1.47 billion, according to LSEG data.

It, however, expects to see sequential growth in its net bookings in fiscals 2026 and 2027.

"Grand Theft Auto" is one of Take-Two's most popular properties, with the franchise having accumulated billions of dollars in revenue since its inception in the late-nineties.

The company in May narrowed the release window for the highly anticipated "Grand Theft Auto VI" to fall of 2025, setting the stage for the launch of the next installment of one of the most popular video game franchises in the world.

The company reported first-quarter bookings of $1.22 billion, missing analysts' estimate of $1.25 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Taiwan Semiconductor's Arizona Trials Match Taiwanese Plants' Productivity
Market Chatter: Taiwan Semiconductor's Arizona Trials Match Taiwanese Plants' Productivity
Sep 6, 2024
09:10 AM EDT, 09/06/2024 (MT Newswires) -- Taiwan Semiconductor Manufacturing ( TSM ) achieved productivity levels at its Arizona facility on par with its Taiwan-based plants, an indicator its big US project is on the right path, Bloomberg reported, citing a person familiar with the matter. In trial production at its first advanced US plant, the chipmaker's yield rate was...
Guidewire Q4 Beats Estimates, Revenue And ARR Surge
Guidewire Q4 Beats Estimates, Revenue And ARR Surge
Sep 6, 2024
Guidewire Software, Inc. ( GWRE ) shares are trading higher after the company reported fourth-quarter results on Thursday. Total revenue rose 8% Y/Y to $291.5 million, beating the consensus of $283.9 million. Subscription and support revenue increased by 29% Y/Y to $151.8 million, while license revenue decreased by 12% Y/Y to $88.9 million. Also, Services revenue fell by 2% to...
Ventyx Biosciences Doses First Patient in Phase 2a Parkinson's Drug Trial
Ventyx Biosciences Doses First Patient in Phase 2a Parkinson's Drug Trial
Sep 6, 2024
09:00 AM EDT, 09/06/2024 (MT Newswires) -- Ventyx Biosciences ( VTYX ) said Friday it has dosed the first patient in a phase 2a trial of its drug candidate VTX3232 for early-stage Parkinson's disease. The company said the study will assess the safety and tolerability of VTX3232, a selective NLRP3 inhibitor, over a 28-day treatment period involving about 10 patients....
Milestone Pharmaceuticals' Partner Ji Xing's Phase 3 Trial of Etripamil Meets Primary Endpoint
Milestone Pharmaceuticals' Partner Ji Xing's Phase 3 Trial of Etripamil Meets Primary Endpoint
Sep 6, 2024
09:08 AM EDT, 09/06/2024 (MT Newswires) -- Milestone Pharmaceuticals ( MIST ) said Friday that its licensing partner Ji Xing Pharmaceuticals reported that a phase 3 trial in China evaluating etripamil nasal spray to treat paroxysmal supraventricular tachycardia met its primary endpoint. Ji Xing said the results show a statistically significant greater proportion of patients who took etripamil converted PSVT...
Copyright 2023-2025 - www.financetom.com All Rights Reserved